Form 4 for TECH Bio-Techne
Accepted 2023-01-06 00:00:00 ET · period of report 2023-01-04 · accession 0001062993-23-000628 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-06 | 2023-01-04 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $26.65 | +407.4K | 1.37M | +42% | +$10.86M |
| D | 2023-01-06 | 2023-01-04 | TECH | Kummeth Charles R. | CEO, Dir | F - Tax | $84.39 | -255.8K | 1.11M | -19% | -$21.59M |
| D | 2023-01-06 | 2023-01-04 | TECH | Kummeth Charles R. | CEO, Dir | M - OptEx | $0.00 | -407.4K | 616.7K | -40% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-04 | M | A | 407,364 | $26.65 | 1,368,976 | D | — | — | (F1) Includes (i) 11,448 shares of restricted stock for which the risk of forfeiture will lapse on August 5, 2023; and (ii) 14,248 shares of restricted stock for which the risk of forfeiture will lapse as to 7,128 shares on each of August 6, 2023 and August 6, 2024. |
| 2 | Common | Common Stock | 2023-01-04 | F | D | 255,837 | $84.39 | 1,113,139 | D | — | — | |
| 3 | Derivative | Stock Options (Right to Buy) | 2023-01-04 | M | D | 407,364 | $0.00 | 616,676 | D | $26.65 · — to 2023-08-18 | 407,364 Common Stock | (F2) Fully exercisable. |